Top 10 Key Players in the Taiwan Restless Leg Syndrome Market | Companies & Insights 2026

Top 10 Key Players in the Taiwan Restless Leg Syndrome Market

The Taiwan Restless Leg Syndrome (RLS) Market is undergoing steady expansion, with leading companies having a high market share through wide distribution networks and innovative treatments. Key players in this market include Boehringer Ingelheim Taiwan, GSK Taiwan, UCB Taiwan, and Yung Shin Pharmaceutical.

Taiwan Restless Leg Syndrome Market Overview

According to 6Wresearch, the Taiwan Restless Leg Syndrome Market is estimated to grow, due to an increase in neurological disorders and awareness among consumers regarding sleep-related health. The growing prevalence of RLS has fuelled the demand for effective treatments, such as dopamine agonists, iron supplements, and anti-seizure medications.

The increase in lifestyle-related sleep disturbances and neurological conditions due to regular stress and an aging population is further boosting the market of restless leg syndrome. The growing awareness regarding healthcare and new formulations in medications, including extended-release dopamine agonists and transdermal patches, is set to increase the market growth for long term.

Competitive Landscape

The competitive landscape of the Taiwan Restless Leg Syndrome industry is influenced by the investments of leading companies in research, development, and distribution. The dominant pharmaceutical players are focusing on the development of various types of treatment options, including over-the-counter supplements and prescription drugs, to meet the different needs of patients.

Below is a list of leading players operating in the Taiwan Restless Leg Syndrome Market:

1. Boehringer Ingelheim Taiwan

Boehringer Ingelheim is a market leader with its flagship product Sifrol, which is widely prescribed for moderate-to-severe idiopathic RLS.

2. GlaxoSmithKline (GSK) Taiwan

GSK remains a significant player by providing ropinirole-based treatments that target the dopamine receptors responsible for the urge to move legs.

3. UCB Taiwan

UCB provides the Neupro patch, a continuous transdermal delivery system that offers a unique 24-hour treatment option for RLS patients.

4. Yung Shin Pharmaceutical Ind. Co., Ltd.

Yung Shin is a dominant local manufacturer producing high-quality generic dopamine agonists and supplements used in managing chronic RLS symptoms.

5. Sinphar Pharmaceutical Co., Ltd.

Sinphar specializes in oral preparations and vitamin-based support therapies, often used as adjunctive treatments for patients with mild RLS symptoms.

6. Pfizer Taiwan

Pfizer is active in the market through the distribution of gabapentinoid medications, which are frequently used for patients who are non-responsive to traditional therapy.

7. Novartis Taiwan

Novartis provides neurological solutions and focuses on the underlying causes of RLS, including iron metabolism and secondary neurological triggers.

8. Eisai Taiwan

Eisai offers specialized medications and clinical support for movement disorders and sleep-wake cycle disturbances associated with RLS.

9. Takeda Pharmaceuticals Taiwan

Takeda partners with medical centres to provide treatments for gastrointestinal-related RLS, specifically targeting patients with iron absorption issues.

10. Standard Chem & Pharm Co., Ltd.

Standard Chem & Pharm focuses on the production of cost-effective generic sedative-hypnotics and muscle relaxants used to manage RLS-induced insomnia.

Top 10 Key Players in the Taiwan Restless Leg Syndrome Market: FAQs